Global K Cells Market Size, Status and Forecast 2020-2026
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by K Cells Revenue
- 1.4 Market by Type
- 1.4.1 Global K Cells Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Mogamulizumab
- 1.4.3 Lorvotuzumab Mertansine
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global K Cells Market Share by Application: 2020 VS 2026
- 1.5.2 Cancer
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global K Cells Market Perspective (2015-2026)
- 2.2 Global K Cells Growth Trends by Regions
- 2.2.1 K Cells Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 K Cells Historic Market Share by Regions (2015-2020)
- 2.2.3 K Cells Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 K Cells Market Growth Strategy
- 2.3.6 Primary Interviews with Key K Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top K Cells Players by Market Size
- 3.1.1 Global Top K Cells Players by Revenue (2015-2020)
- 3.1.2 Global K Cells Revenue Market Share by Players (2015-2020)
- 3.1.3 Global K Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global K Cells Market Concentration Ratio
- 3.2.1 Global K Cells Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by K Cells Revenue in 2019
- 3.3 K Cells Key Players Head office and Area Served
- 3.4 Key Players K Cells Product Solution and Service
- 3.5 Date of Enter into K Cells Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global K Cells Historic Market Size by Type (2015-2020)
- 4.2 Global K Cells Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global K Cells Market Size by Application (2015-2020)
- 5.2 Global K Cells Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America K Cells Market Size (2015-2020)
- 6.2 K Cells Key Players in North America (2019-2020)
- 6.3 North America K Cells Market Size by Type (2015-2020)
- 6.4 North America K Cells Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe K Cells Market Size (2015-2020)
- 7.2 K Cells Key Players in Europe (2019-2020)
- 7.3 Europe K Cells Market Size by Type (2015-2020)
- 7.4 Europe K Cells Market Size by Application (2015-2020)
8 China
- 8.1 China K Cells Market Size (2015-2020)
- 8.2 K Cells Key Players in China (2019-2020)
- 8.3 China K Cells Market Size by Type (2015-2020)
- 8.4 China K Cells Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan K Cells Market Size (2015-2020)
- 9.2 K Cells Key Players in Japan (2019-2020)
- 9.3 Japan K Cells Market Size by Type (2015-2020)
- 9.4 Japan K Cells Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia K Cells Market Size (2015-2020)
- 10.2 K Cells Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia K Cells Market Size by Type (2015-2020)
- 10.4 Southeast Asia K Cells Market Size by Application (2015-2020)
11 India
- 11.1 India K Cells Market Size (2015-2020)
- 11.2 K Cells Key Players in India (2019-2020)
- 11.3 India K Cells Market Size by Type (2015-2020)
- 11.4 India K Cells Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America K Cells Market Size (2015-2020)
- 12.2 K Cells Key Players in Central & South America (2019-2020)
- 12.3 Central & South America K Cells Market Size by Type (2015-2020)
- 12.4 Central & South America K Cells Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Takeda Pharmaceutical (Japan)
- 13.1.1 Takeda Pharmaceutical (Japan) Company Details
- 13.1.2 Takeda Pharmaceutical (Japan) Business Overview
- 13.1.3 Takeda Pharmaceutical (Japan) K Cells Introduction
- 13.1.4 Takeda Pharmaceutical (Japan) Revenue in K Cells Business (2015-2020))
- 13.1.5 Takeda Pharmaceutical (Japan) Recent Development
- 13.2 Sorrento Therapeutics Inc. (USA)
- 13.2.1 Sorrento Therapeutics Inc. (USA) Company Details
- 13.2.2 Sorrento Therapeutics Inc. (USA) Business Overview
- 13.2.3 Sorrento Therapeutics Inc. (USA) K Cells Introduction
- 13.2.4 Sorrento Therapeutics Inc. (USA) Revenue in K Cells Business (2015-2020)
- 13.2.5 Sorrento Therapeutics Inc. (USA) Recent Development
- 13.3 NantKwest Inc. (USA)
- 13.3.1 NantKwest Inc. (USA) Company Details
- 13.3.2 NantKwest Inc. (USA) Business Overview
- 13.3.3 NantKwest Inc. (USA) K Cells Introduction
- 13.3.4 NantKwest Inc. (USA) Revenue in K Cells Business (2015-2020)
- 13.3.5 NantKwest Inc. (USA) Recent Development
- 13.4 Bristol-Myers Squibb (USA)
- 13.4.1 Bristol-Myers Squibb (USA) Company Details
- 13.4.2 Bristol-Myers Squibb (USA) Business Overview
- 13.4.3 Bristol-Myers Squibb (USA) K Cells Introduction
- 13.4.4 Bristol-Myers Squibb (USA) Revenue in K Cells Business (2015-2020)
- 13.4.5 Bristol-Myers Squibb (USA) Recent Development
- 13.5 NKT Therapeutics (USA)
- 13.5.1 NKT Therapeutics (USA) Company Details
- 13.5.2 NKT Therapeutics (USA) Business Overview
- 13.5.3 NKT Therapeutics (USA) K Cells Introduction
- 13.5.4 NKT Therapeutics (USA) Revenue in K Cells Business (2015-2020)
- 13.5.5 NKT Therapeutics (USA) Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
K Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global K Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
...
Market segment by Type, the product can be split into
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market segment by Application, split into
Cancer
Cardiovascular Diseases
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America